Catalyst Wire Dossier Catalyst Wire Dossier

IMKELDI

Imatinib · Shorla Oncology Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMKELDI, covering 2024-11-22 to 2024-11-22. Get the full timeline:

Most recent: FDA Approved: IMKELDI — Original Application (Shorla Oncology Inc.,)

See pricing